(Q28265304)

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

The pathology of familial breast cancer: Morphological aspects

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Frequency of CHEK2*1100delC in New York breast cancer cases and controls

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

The pathology of familial breast cancer: Immunohistochemistry and molecular analysis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Molecular portraits of human breast tumours

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

In search of the tumour-suppressor functions of BRCA1 and BRCA2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Gene expression profiling predicts clinical outcome of breast cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

A gene-expression signature as a predictor of survival in breast cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Cancer susceptibility and the functions of BRCA1 and BRCA2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209875

Identification of the breast cancer susceptibility gene BRCA2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

BRCA1 functions as a breast stem cell regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Low expression of bcl-2 in Brca1-associated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Molecular classification of familial non-BRCA1/BRCA2 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer DifferentiateBRCA2-Associated Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Epithelial lesions in prophylactic mastectomy specimens from women withBRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Allele Imbalance, or Loss of Heterozygosity, in Normal Breast Epithelium of Sporadic Breast Cancer Cases andBRCA1Gene Mutation Carriers Is Increased Compared With Reduction Mammoplasty Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

Inherited BRCA2 mutation associated with high grade breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Novel indications for BRCA1 screening using individual clinical and morphological features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Pathology of breast cancer in women with constitutional CHEK2 mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Genetic alterations in 'normal' luminal and myoepithelial cells of the breast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Pathobiologic characteristics of hereditary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

BRCA2 hereditary breast cancer pathophenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Tissue microarrays for comparing molecular features with proliferation activity in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021

Phenotypic effects of heterozygosity for a BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209875

7 January 2021